MTCP1 and leukemia: While mechanisms supporting the observed variance in leukemia onset between Z20 and Z36 founder lines remain unresolved, insertion of the MTCP1 transgene in proximity to additional active enhancer regions or inaccessible in regions of condensed chromatin may be contributing to this distinction.